NICE has published draft guidance recommending that women with type 1 diabetes who are pregnant or planning a pregnancy should be offered a pregnancy-specific “artificial pancreas” device, in a move the organization says could improve care for patients managing the condition during a high-risk period. The guidance was published on 3 June 2026.
What the new guidance says
The recommendation focuses on a pregnancy-specific device designed for women with type 1 diabetes. According to NICE, the guidance was published as draft guidance and sets out that women who are pregnant or planning a pregnancy should be offered the technology.
The move follows a series of recent NICE announcements on health technologies and comes as the organization continues to publish new guidance across major treatment areas. NICE’s news pages show the pregnancy-specific artificial pancreas guidance alongside other recent decisions, including new treatment recommendations for ovarian cancer and updates on liver preservation machines for transplant patients. ([nice.org.uk](https://www.nice.org.uk/news/articles))
Why the recommendation matters
Type 1 diabetes requires careful management at all times, and pregnancy can make that management more complex. NICE’s draft guidance signals that the technology is being positioned as an option for women who are pregnant or planning pregnancy, reflecting the organization’s continued focus on digital and device-based support in the NHS.
The guidance is part of a broader recent wave of NICE health technology activity. On its news page, the organization also highlights a consultation on specialist liver preservation machines and a recommendation for the first new NHS treatment in over 20 years for women with resistant ovarian cancer. ([nice.org.uk](https://www.nice.org.uk/news/articles))
Broader NHS technology push
NICE has been using its news platform to announce multiple technology and treatment updates in recent weeks, indicating an active pipeline of guidance affecting NHS care. Its published news list for 2026 includes the artificial pancreas guidance, new liver preservation machines, and routine NHS access to spinal muscular atrophy treatments. ([nice.org.uk](https://www.nice.org.uk/news/articles))
For patients and clinicians, the key question now will be how quickly any final guidance is confirmed and how the technology is implemented in practice across the NHS. For now, the draft recommendation underscores the growing role of specialist medical technology in pregnancy care.
More details are available on the NICE news articles page. ([nice.org.uk](https://www.nice.org.uk/news/articles))
